Antimicrobial biomaterials: challenges involved in closing the gap between idea and commercial product
Biofilm-associated cells disclose an organized structure able to drastically resist antimicrobial agents and host immune responses. In view of the serious impact of biofilms on human health, potential strategies to fight oral disease have been notoriously explored through the antimicrobial-based possibilities capable of interfering with the bacterial adhesion process. However, the lack of commercial antimicrobial products raises some questions regarding the challenges involved in developing a marketable invention. Challenges might be related both to the building and functionalization of the antimicrobial biomaterial, as well as to the understanding of how to make a product commercially viable and interesting for the industry. This Collection presents original studies touching on the impact of biomaterials-based antimicrobial strategies on overall oral diseases, through different biofilm models, and the potential cellular risks associated with exposure to these compounds.
Guest editors
Erica Dorigatti de Avila(Sao Paolo State University (UNESP))
Sponsored by
